These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35051492)
1. The prognostic value of time from symptom onset to thrombolysis in patients with pulmonary embolism. Keskin M; Dogan S; Kaya A; Tenekecioğlu E; Ocal L; Cersit S; Seker M; Yavuz S; Orhan AL Int J Cardiol; 2022 Apr; 352():131-136. PubMed ID: 35051492 [TBL] [Abstract][Full Text] [Related]
2. Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis. Patel N; Patel NJ; Agnihotri K; Panaich SS; Thakkar B; Patel A; Savani C; Patel N; Arora S; Deshmukh A; Bhatt P; Alfonso C; Cohen M; Tafur A; Elder M; Mohamed T; Attaran R; Schreiber T; Grines C; Badheka AO Catheter Cardiovasc Interv; 2015 Dec; 86(7):1219-27. PubMed ID: 26308961 [TBL] [Abstract][Full Text] [Related]
3. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism. Riera-Mestre A; Jiménez D; Muriel A; Lobo JL; Moores L; Yusen RD; Casado I; Nauffal D; Oribe M; Monreal M; J Thromb Haemost; 2012 May; 10(5):751-9. PubMed ID: 22417297 [TBL] [Abstract][Full Text] [Related]
9. Practice patterns and complication rates of thrombolysis for pulmonary embolism. Bradford MA; Lindenauer PK; Walkey AJ J Thromb Thrombolysis; 2016 Oct; 42(3):313-21. PubMed ID: 26961258 [TBL] [Abstract][Full Text] [Related]
10. Effects of Thrombolytic Therapy in Low-Risk Patients With Pulmonary Embolism. Stein PD; Matta F; Hughes MJ Am J Cardiol; 2021 Jan; 139():116-120. PubMed ID: 32991851 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Effectiveness between Anticoagulation and Thrombolysis Therapy for Pulmonary Embolism in Patients Complicated with Shock: A Nationwide Population-Based Study. Lee JK; Chen WH; Lin YS; Chang CH; Chen TH Thromb Haemost; 2020 Aug; 120(8):1208-1216. PubMed ID: 32679597 [TBL] [Abstract][Full Text] [Related]
12. Midterm Prognosis of Patients With Pulmonary Embolism Receiving Catheter-Directed Thrombolysis or Systemic Thrombolysis: A Nationwide Population-Based Study. Lin DS; Lin YS; Wu CK; Lin HH; Lee JK J Am Heart Assoc; 2021 Apr; 10(7):e019296. PubMed ID: 33787288 [TBL] [Abstract][Full Text] [Related]
13. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Keller K; Hobohm L; Ebner M; Kresoja KP; Münzel T; Konstantinides SV; Lankeit M Eur Heart J; 2020 Jan; 41(4):522-529. PubMed ID: 31102407 [TBL] [Abstract][Full Text] [Related]
14. Clinical update on thrombolytic use in pulmonary embolism: A focus on intermediate-risk patients. Eberle H; Lyn R; Knight T; Hodge E; Daley M Am J Health Syst Pharm; 2018 Sep; 75(17):1275-1285. PubMed ID: 29895520 [TBL] [Abstract][Full Text] [Related]
15. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. Konstantinides SV; Vicaut E; Danays T; Becattini C; Bertoletti L; Beyer-Westendorf J; Bouvaist H; Couturaud F; Dellas C; Duerschmied D; Empen K; Ferrari E; Galiè N; Jiménez D; Kostrubiec M; Kozak M; Kupatt C; Lang IM; Lankeit M; Meneveau N; Palazzini M; Pruszczyk P; Rugolotto M; Salvi A; Sanchez O; Schellong S; Sobkowicz B; Meyer G J Am Coll Cardiol; 2017 Mar; 69(12):1536-1544. PubMed ID: 28335835 [TBL] [Abstract][Full Text] [Related]
16. In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. Meneveau N; Ming LP; Séronde MF; Mersin N; Schiele F; Caulfield F; Bernard Y; Bassand JP Eur Heart J; 2003 Aug; 24(15):1447-54. PubMed ID: 12909074 [TBL] [Abstract][Full Text] [Related]
17. Systemic or local thrombolysis in high-risk pulmonary embolism. Macovei L; Presura RM; Arsenescu Georgescu C Cardiol J; 2015; 22(4):467-74. PubMed ID: 25563712 [TBL] [Abstract][Full Text] [Related]